Setting

Asia Pacific Bioanalytical Testing Services Market 2021-2031 by Molecule Type (Small, Large), Application (Bioavailability and Bioequivalence, PK, PD, ADME), Test Type (Cell-based, Virology, SINA, MDOV, Biomarker), Workflow Process (Sample Preparation, Sample Analysis, Others), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User (Pharma and Biopharma Companies, CDMOs, CROs), and Country: Trend Forecast and Growth Opportunity

Published: 31 Mar 2022 | Report Code: 10248435 | Pages: 136

Asia Pacific bioanalytical testing services market will grow by 11.2% annually with a total addressable market cap of $ 13,359.1 million over 2022-2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design (QbD) approach. Highlighted with 36 tables and 78 figures, this 136-page report “Asia Pacific Bioanalytical Testing Services Market 2021-2031 by Molecule Type (Small, Large), Application (Bioavailability and Bioequivalence, PK, PD, ADME), Test Type (Cell-based, Virology, SINA, MDOV, Biomarker), Workflow Process (Sample Preparation, Sample Analysis, Others), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User (Pharma and Biopharma Companies, CDMOs, CROs), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific bioanalytical testing services market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific bioanalytical testing services market in every aspect of the classification from perspectives of Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Country. Based on Molecule Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Small Molecules • Large Molecules o LC-MS Studies o Immunoassays o Other Large Molecule Tests Based Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Bioavailability and Bioequivalence Studies • Pharmacokinetics (PK) • Pharmacodynamics (PD) • Absorption, Distribution, Metabolism, Excretion (ADME) • Other Applications By Test Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Cell-based Assays o Bacterial Cell-based Assays o Viral Cell-based Assays • Virology Testing o In Vitro Virology Testing o In Vivo Virology Testing o Species-Specific Viral PCR Assays • Serology, Immunogenicity, and Neutralizing Antibodies (SINA) o Bacterial Serology, Immunogenicity, and Neutralizing Antibodies o Viral Serology, Immunogenicity, and Neutralizing Antibodies • Method Development Optimization and Validation (MDOV) • Biomarker Testing • Pharmacokinetic Testing • Other Test Types By Workflow Process, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Sample Preparation o Protein Precipitation o Liquid-liquid Extraction (LLE) • Sample Analysis o Hyphenated Technique o Chromatographic Technique o Electrophoresis o Ligand Binding Assay o Mass Spectrometry o Nuclear Magnetic Resonance • Other Workflow Processes By Therapeutic Area, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Oncology • Neurology • Infectious Diseases • Gastroenterology • Cardiology • Other Therapeutic Areas By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pharma and Biopharma Companies • Contract Development and Manufacturing Organizations (CDMOs) • Contract Research Organizations (CROs) Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Application, Workflow Process, and Therapeutic Area over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Charles River Laboratories International Inc. Covance Inc. Eurofins Scientific ICON PLC Intertek Group PLC IQVIA Holdings, Inc. Laboratory Corporation of America Holdings Medpace Holdings, Inc. Pace Analytical Services LLC. Parexel International Corporation PPD Inc. SGS SA Syneos Health, LLC Toxikon Corporation WuXi Apptech Co., Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

	8
1.1 Industry Definition and Research Scope	8
1.1.1 Industry Definition	8
1.1.2 Research Scope	9
1.2 Research Methodology	12
1.2.1 Overview of Market Research Methodology	12
1.2.2 Market Assumption	13
1.2.3 Secondary Data	13
1.2.4 Primary Data	13
1.2.5 Data Filtration and Model Design	14
1.2.6 Market Size/Share Estimation	15
1.2.7 Research Limitations	16
1.3 Executive Summary	17
2 Market Overview and Dynamics	20
2.1 Market Size and Forecast	20
2.1.1 Impact of COVID-19 on World Economy	21
2.1.2 Impact of COVID-19 on the Market	23
2.2 Major Growth Drivers	28
2.3 Market Restraints and Challenges	31
2.4 Emerging Opportunities and Market Trends	34
2.5 Porter’s Fiver Forces Analysis	38
3 Segmentation of Asia Pacific Market by Molecule Type	42
3.1 Market Overview by Molecule Type	42
3.2 Small Molecules	44
3.3 Large Molecules	45
3.3.1 LC-MS Studies	46
3.3.2 Immunoassays	47
3.3.3 Other Large Molecule Tests	48
4 Segmentation of Asia Pacific Market by Application	49
4.1 Market Overview by Application	49
4.2 Bioavailability and Bioequivalence Studies	51
4.3 Pharmacokinetics (PK)	52
4.4 Pharmacodynamics (PD)	53
4.5 Absorption, Distribution, Metabolism, Excretion (ADME)	54
4.6 Other Applications	55
5 Segmentation of Asia Pacific Market by Test Type	56
5.1 Market Overview by Test Type	56
5.2 Cell-based Assays	58
5.2.1 Bacterial Cell-based Assays	59
5.2.2 Viral Cell-based Assays	60
5.3 Virology Testing	61
5.3.1 In Vitro Virology Testing	62
5.3.2 In Vivo Virology Testing	63
5.3.3 Species-Specific Viral PCR Assays	64
5.4 Serology, Immunogenicity, and Neutralizing Antibodies (SINA)	65
5.4.1 Bacterial Serology, Immunogenicity, and Neutralizing Antibodies	66
5.4.2 Viral Serology, Immunogenicity, and Neutralizing Antibodies	67
5.5 Method Development Optimization and Validation (MDOV)	68
5.6 Biomarker Testing	69
5.7 Pharmacokinetic Testing	70
5.8 Other Test Types	71
6 Segmentation of Asia Pacific Market by Workflow Process	72
6.1 Market Overview by Workflow Process	72
6.2 Sample Preparation	74
6.2.1 Protein Precipitation	75
6.2.2 Liquid-liquid Extraction (LLE)	76
6.2.3 Solid Phase Extraction (SPE)	77
6.3 Sample Analysis	78
6.3.1 Hyphenated Technique	80
6.3.2 Chromatographic Technique	81
6.3.3 Electrophoresis	82
6.3.4 Ligand Binding Assay	83
6.3.5 Mass Spectrometry	84
6.3.6 Nuclear Magnetic Resonance	85
6.4 Other Workflow Processes	86
7 Segmentation of Asia Pacific Market by Therapeutic Area	87
7.1 Market Overview by Therapeutic Area	87
7.2 Oncology	89
7.3 Neurology	90
7.4 Infectious Diseases	91
7.5 Gastroenterology	92
7.6 Cardiology	93
7.7 Other Therapeutic Areas	94
8 Segmentation of Asia Pacific Market by End User	95
8.1 Market Overview by End User	95
8.2 Pharma and Biopharma Companies	97
8.3 Contract Development and Manufacturing Organizations (CDMOs)	98
8.4 Contract Research Organizations (CROs)	99
9 Asia-Pacific Market 2021-2031 by Country	100
9.1 Overview of Asia-Pacific Market	100
9.2 Japan	103
9.3 China	106
9.4 Australia	108
9.5 India	110
9.6 South Korea	112
9.7 Rest of APAC Region	114
10 Competitive Landscape	116
10.1 Overview of Key Vendors	116
10.2 New Product Launch, Partnership, Investment, and M&A	119
10.3 Company Profiles	120
Charles River Laboratories International Inc.	120
Covance Inc.	122
Eurofins Scientific	123
ICON PLC	124
Intertek Group PLC	125
IQVIA Holdings, Inc.	126
Laboratory Corporation of America Holdings	127
Medpace Holdings, Inc.	128
Pace Analytical Services LLC.	129
Parexel International Corporation	130
PPD Inc.	131
SGS SA	132
Syneos Health, LLC	133
Toxikon Corporation	134
WuXi Apptech Co., Ltd.	135
RELATED REPORTS	136
List Of Tables:


Table 1.  Snapshot of Asia Pacific Bioanalytical Testing Services Market in Balanced Perspective, 2021-2031	18
Table 2. World Economic Outlook, 2021-2031	22
Table 3. World Health Spending by Region, $ bn, 2013-2020	27
Table 4.  Main Product Trends and Market Opportunities in Asia Pacific Bioanalytical Testing Services Market	34
Table 5. Asia Pacific Bioanalytical Testing Services Market by Molecule Type, 2021-2031, $ mn	42
Table 6. Asia Pacific Bioanalytical Testing Services Market: Large Molecules Testing by Technology, 2021-2031, $ mn	45
Table 7. Asia Pacific Bioanalytical Testing Services Market by Application, 2021-2031, $ mn	49
Table 8. Asia Pacific Bioanalytical Testing Services Market by Test Type, 2021-2031, $ mn	56
Table 9. Asia Pacific Bioanalytical Testing Services Market: Cell-based Assays by Type, 2021-2031, $ mn	58
Table 10. Asia Pacific Bioanalytical Testing Services Market: Virology Testing by Type, 2021-2031, $ mn	61
Table 11. Asia Pacific Bioanalytical Testing Services Market: Serology, Immunogenicity, and Neutralizing Antibodies (SINA) by Type, 2021-2031, $ mn	65
Table 12. Asia Pacific Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn	72
Table 13. Asia Pacific Bioanalytical Testing Services Market: Sample Preparation by Method, 2021-2031, $ mn	74
Table 14. Asia Pacific Bioanalytical Testing Services Market: Sample Analysis by Technology, 2021-2031, $ mn	79
Table 15. Asia Pacific Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn	87
Table 16. Asia Pacific Bioanalytical Testing Services Market by End User, 2021-2031, $ mn	95
Table 17. APAC Bioanalytical Testing Services Market by Country, 2021-2031, $ mn	101
Table 18. Japan Bioanalytical Testing Services Market by Application, 2021-2031, $ mn	105
Table 19. Japan Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn	105
Table 20. Japan Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn	105
Table 21. China Bioanalytical Testing Services Market by Application, 2021-2031, $ mn	107
Table 22. China Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn	107
Table 23. China Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn	107
Table 24. Australia Bioanalytical Testing Services Market by Application, 2021-2031, $ mn	109
Table 25. Australia Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn	109
Table 26. Australia Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn	109
Table 27. India Bioanalytical Testing Services Market by Application, 2021-2031, $ mn	111
Table 28. India Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn	111
Table 29. India Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn	111
Table 30. South Korea Bioanalytical Testing Services Market by Application, 2021-2031, $ mn	113
Table 31. South Korea Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn	113
Table 32. South Korea Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn	113
Table 33. Bioanalytical Testing Services Market in Rest of APAC by Country/Region, 2021-2031, $ mn	115
Table 34. Charles River Laboratories International Inc.: Company Snapshot	120
Table 35. Charles River Laboratories International Inc.: Business Segmentation	121
Table 36. Charles River Laboratories International Inc.: Product Portfolio	121
List Of Figures:


Figure 1. Research Method Flow Chart	12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	15
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	17
Figure 4. Asia Pacific Bioanalytical Testing Services Market, 2021-2031, $ mn	20
Figure 5. Impact of COVID-19 on Business	23
Figure 6.  Leading Causes of Death in the World, 2019-2020, million	25
Figure 7.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	26
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060	26
Figure 9. Primary Drivers and Impact Factors of Asia Pacific Bioanalytical Testing Services Market	28
Figure 10. Primary Restraints and Impact Factors of Asia Pacific Bioanalytical Testing Services Market	31
Figure 11. Investment Opportunity Analysis	35
Figure 12. Porter’s Fiver Forces Analysis of Asia Pacific Bioanalytical Testing Services Market	38
Figure 13. Breakdown of Asia Pacific Bioanalytical Testing Services Market by Molecule Type, 2021-2031, % of Revenue	43
Figure 14. Asia Pacific Addressable Market Cap in 2022-2031 by Molecule Type, Value ($ mn) and Share (%)	43
Figure 15. Asia Pacific Bioanalytical Testing Services Market by Molecule Type: Small Molecules, 2021-2031, $ mn	44
Figure 16. Asia Pacific Bioanalytical Testing Services Market by Molecule Type: Large Molecules, 2021-2031, $ mn	45
Figure 17. Asia Pacific Bioanalytical Testing Services Market by Large Molecules: LC-MS Studies, 2021-2031, $ mn	46
Figure 18. Asia Pacific Bioanalytical Testing Services Market by Large Molecules: Immunoassays, 2021-2031, $ mn	47
Figure 19. Asia Pacific Bioanalytical Testing Services Market by Large Molecules: Other Large Molecule Tests, 2021-2031, $ mn	48
Figure 20. Breakdown of Asia Pacific Bioanalytical Testing Services Market by Application, 2021-2031, % of Sales Revenue	50
Figure 21. Asia Pacific Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)	50
Figure 22. Asia Pacific Bioanalytical Testing Services Market by Application: Bioavailability and Bioequivalence Studies, 2021-2031, $ mn	51
Figure 23. Asia Pacific Bioanalytical Testing Services Market by Application: Pharmacokinetics (PK), 2021-2031, $ mn	52
Figure 24. Asia Pacific Bioanalytical Testing Services Market by Application: Pharmacodynamics (PD), 2021-2031, $ mn	53
Figure 25. Asia Pacific Bioanalytical Testing Services Market by Application: Absorption, Distribution, Metabolism, Excretion (ADME), 2021-2031, $ mn	54
Figure 26. Asia Pacific Bioanalytical Testing Services Market by Application: Other Applications, 2021-2031, $ mn	55
Figure 27. Breakdown of Asia Pacific Bioanalytical Testing Services Market by Test Type, 2021-2031, % of Sales Revenue	57
Figure 28. Asia Pacific Addressable Market Cap in 2022-2031 by Test Type, Value ($ mn) and Share (%)	57
Figure 29. Asia Pacific Bioanalytical Testing Services Market by Test Type: Cell-based Assays, 2021-2031, $ mn	58
Figure 30. Asia Pacific Bioanalytical Testing Services Market by Cell-based Assays: Bacterial Cell-based Assays, 2021-2031, $ mn	59
Figure 31. Asia Pacific Bioanalytical Testing Services Market by Cell-based Assays: Viral Cell-based Assays, 2021-2031, $ mn	60
Figure 32. Asia Pacific Bioanalytical Testing Services Market by Test Type: Virology Testing, 2021-2031, $ mn	61
Figure 33. Asia Pacific Bioanalytical Testing Services Market by Virology Testing: In Vitro Virology Testing, 2021-2031, $ mn	62
Figure 34. Asia Pacific Bioanalytical Testing Services Market by Virology Testing: In Vivo Virology Testing, 2021-2031, $ mn	63
Figure 35. Asia Pacific Bioanalytical Testing Services Market by Virology Testing: Species-Specific Viral PCR Assays, 2021-2031, $ mn	64
Figure 36. Asia Pacific Bioanalytical Testing Services Market by Test Type: Serology, Immunogenicity, and Neutralizing Antibodies (SINA), 2021-2031, $ mn	65
Figure 37. Asia Pacific Bioanalytical Testing Services Market by Serology, Immunogenicity, and Neutralizing Antibodies (SINA): Bacterial Serology, Immunogenicity, and Neutralizing Antibodies, 2021-2031, $ mn	66
Figure 38. Asia Pacific Bioanalytical Testing Services Market by Serology, Immunogenicity, and Neutralizing Antibodies (SINA): Viral Serology, Immunogenicity, and Neutralizing Antibodies, 2021-2031, $ mn	67
Figure 39. Asia Pacific Bioanalytical Testing Services Market by Test Type: Method Development Optimization and Validation (MDOV), 2021-2031, $ mn	68
Figure 40. Asia Pacific Bioanalytical Testing Services Market by Test Type: Biomarker Testing, 2021-2031, $ mn	69
Figure 41. Asia Pacific Bioanalytical Testing Services Market by Test Type: Pharmacokinetic Testing, 2021-2031, $ mn	70
Figure 42. Asia Pacific Bioanalytical Testing Services Market by Test Type: Other Test Types, 2021-2031, $ mn	71
Figure 43. Breakdown of Asia Pacific Bioanalytical Testing Services Market by Workflow Process, 2021-2031, % of Revenue	73
Figure 44. Asia Pacific Addressable Market Cap in 2022-2031 by Workflow Process, Value ($ mn) and Share (%)	73
Figure 45. Asia Pacific Bioanalytical Testing Services Market by Workflow Process: Sample Preparation, 2021-2031, $ mn	74
Figure 46. Asia Pacific Bioanalytical Testing Services Market by Sample Preparation: Protein Precipitation, 2021-2031, $ mn	75
Figure 47. Asia Pacific Bioanalytical Testing Services Market by Sample Preparation: Liquid-liquid Extraction (LLE), 2021-2031, $ mn	76
Figure 48. Asia Pacific Bioanalytical Testing Services Market by Sample Preparation: Solid Phase Extraction (SPE), 2021-2031, $ mn	77
Figure 49. Asia Pacific Bioanalytical Testing Services Market by Workflow Process: Sample Analysis, 2021-2031, $ mn	78
Figure 50. Asia Pacific Bioanalytical Testing Services Market by Sample Analysis: Hyphenated Technique, 2021-2031, $ mn	80
Figure 51. Asia Pacific Bioanalytical Testing Services Market by Sample Analysis: Chromatographic Technique, 2021-2031, $ mn	81
Figure 52. Asia Pacific Bioanalytical Testing Services Market by Sample Analysis: Electrophoresis, 2021-2031, $ mn	82
Figure 53. Asia Pacific Bioanalytical Testing Services Market by Sample Analysis: Ligand Binding Assay, 2021-2031, $ mn	83
Figure 54. Asia Pacific Bioanalytical Testing Services Market by Sample Analysis: Mass Spectrometry, 2021-2031, $ mn	84
Figure 55. Asia Pacific Bioanalytical Testing Services Market by Sample Analysis: Nuclear Magnetic Resonance, 2021-2031, $ mn	85
Figure 56. Asia Pacific Bioanalytical Testing Services Market by Workflow Process: Other Workflow Processes, 2021-2031, $ mn	86
Figure 57. Breakdown of Asia Pacific Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, % of Revenue	88
Figure 58. Asia Pacific Addressable Market Cap in 2022-2031 by Therapeutic Area, Value ($ mn) and Share (%)	88
Figure 59. Asia Pacific Bioanalytical Testing Services Market by Therapeutic Area: Oncology, 2021-2031, $ mn	89
Figure 60. Asia Pacific Bioanalytical Testing Services Market by Therapeutic Area: Neurology, 2021-2031, $ mn	90
Figure 61. Asia Pacific Bioanalytical Testing Services Market by Therapeutic Area: Infectious Diseases, 2021-2031, $ mn	91
Figure 62. Asia Pacific Bioanalytical Testing Services Market by Therapeutic Area: Gastroenterology, 2021-2031, $ mn	92
Figure 63. Asia Pacific Bioanalytical Testing Services Market by Therapeutic Area: Cardiology, 2021-2031, $ mn	93
Figure 64. Asia Pacific Bioanalytical Testing Services Market by Therapeutic Area: Other Therapeutic Areas, 2021-2031, $ mn	94
Figure 65. Breakdown of Asia Pacific Bioanalytical Testing Services Market by End User, 2021-2031, % of Revenue	95
Figure 66. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	96
Figure 67. Asia Pacific Bioanalytical Testing Services Market by End User: Pharma and Biopharma Companies, 2021-2031, $ mn	97
Figure 68. Asia Pacific Bioanalytical Testing Services Market by End User: Contract Development and Manufacturing Organizations (CDMOs), 2021-2031, $ mn	98
Figure 69. Asia Pacific Bioanalytical Testing Services Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn	99
Figure 70. Breakdown of APAC Bioanalytical Testing Services Market by Country, 2021 and 2031, % of Revenue	101
Figure 71. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	102
Figure 72.  Bioanalytical Testing Services Market in Japan, 2021-2031, $ mn	104
Figure 73.  Bioanalytical Testing Services Market in China, 2021-2031, $ mn	106
Figure 74.  Bioanalytical Testing Services Market in Australia, 2021-2031, $ mn	108
Figure 75.  Bioanalytical Testing Services Market in India, 2021-2031, $ mn	110
Figure 76.  Bioanalytical Testing Services Market in South Korea, 2021-2031, $ mn	112
Figure 77.  Bioanalytical Testing Services Market in Rest of APAC, 2021-2031, $ mn	114
Figure 78. Growth Stage of Asia Pacific Bioanalytical Testing Services Industry over the Forecast Period	116

Selected Key Players: 
Charles River Laboratories International Inc.
Covance Inc.
Eurofins Scientific
ICON PLC
Intertek Group PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America Holdings
Medpace Holdings, Inc.
Pace Analytical Services LLC.
Parexel International Corporation
PPD Inc.
SGS SA
Syneos Health, LLC
Toxikon Corporation
WuXi Apptech Co., Ltd. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)